Blood Cells, Molecules, and Diseases (ISSN 1096-0961, 1079-9796) is a journal published by Elsevier in the United States. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Hematology. It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 2.1, Scopus Q2, Web of Science Q3, CiteScore 3.7 and HEC W-Category. Article processing charge: USD 3,960. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Blood Cells, Molecules, and Diseases
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q2 journals · Q3 journals · HEC W category journals · Scopus journals · Web of Science journals · MEDLINE journals · PubMed journals · SCImago journals · SCIE journals · Impact factor journals · Q2 Biochemistry journals · Q2 Genetics and Molecular Biology journals
Quick answers about Blood Cells, Molecules, and Diseases
Is Blood Cells, Molecules, and Diseases HEC recognised?
Yes. The catalogue records Blood Cells, Molecules, and Diseases in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Blood Cells, Molecules, and Diseases indexed in Scopus?
Yes. Blood Cells, Molecules, and Diseases is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 3.7. Check its current status on the Scopus Sources page.
Is Blood Cells, Molecules, and Diseases in Web of Science?
Yes. Blood Cells, Molecules, and Diseases is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q3. Confirm on Clarivate's Master Journal List.
What is the impact factor of Blood Cells, Molecules, and Diseases?
The recorded journal impact factor of Blood Cells, Molecules, and Diseases is 2.1. Clarivate updates impact factors every year in Journal Citation Reports.
Is Blood Cells, Molecules, and Diseases open access, and what does it charge?
Blood Cells, Molecules, and Diseases is not recorded as fully open access and its APC is USD 3,960. Fees change, so check the journal's website before you submit.
Who publishes Blood Cells, Molecules, and Diseases?
Blood Cells, Molecules, and Diseases is published by Elsevier in United States, under ISSN 1096-0961 and 1079-9796.
Research profile
- 3,068articles indexed
- 85,513citations
- 121h-index
- 2.302-year mean citedness
- 1995first year indexed
Main research topics: Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Hematopoietic Stem Cell Transplantation, Hemoglobin structure and function, Glycogen Storage Diseases and Myoclonus, Acute Myeloid Leukemia Research.
Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Biochemistry journals (2,272)
- Genetics and Molecular Biology journals (2,274)
- Medicine journals (8,023)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in MEDLINE (3,645)
- Journals indexed in PubMed (16,086)
- Journals indexed in HEC (34,823)
- Scopus Q2 journals (8,223)
- Web of Science Q3 journals (5,105)
- HEC W-Category journals (13,616)
- Journals published in the United States (7,575)
- Elsevier journals (2,731)